Repros Therapeutics (RPRX) Tops Q3 EPS by 2c
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $58.56 -1.11%
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
OFLX, NMRD, VAXX, More
Financial Fact:
Loss per share - basic and diluted:: -0.17
Today's EPS Names:
OFLX, NMRD, VAXX, More
Join SI Premium – FREE
Repros Therapeutics (NASDAQ: RPRX) reported Q3 EPS of ($0.27), $0.02 better than the analyst estimate of ($0.29).
For earnings history and earnings-related data on Repros Therapeutics (RPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance
- Actelis Networks (ASNS) Tops Q2 EPS by 63c
- Celcuity (CELC) Misses Q2 EPS by 28c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
